Are Investors Interested In Selling Their Holdings Of Fusion Pharmaceuticals Inc (NASDAQ: FUSN)?

Fusion Pharmaceuticals Inc (NASDAQ:FUSN) traded at $21.32 at close of the session on Friday, April 05, made a downward move of -0.51% on its previous day’s price.

Looking at the stock we see that its previous close was $21.43 and the beta (5Y monthly) reads -0.85 . In terms of its 52-week price range, FUSN has a high of $21.55 and a low of $2.31. The company’s stock has gained about 115.35% over that past 30 days.

Fusion Pharmaceuticals Inc has a market cap of $1.81 billion and is expected to release its quarterly earnings report on Mar 14, 2024 – Mar 18, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$0.37, with the EPS growth for the year raised at -$1.51 for 2024 and -$1.76 for next year. These figures represent -4.10% and -16.60% growth in EPS for the two years respectively.

The median projection represents growth squeezing down to 507.10% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $490k, or -76.30% down from figures reported last year.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the FUSN stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.

Looking further, we note the current price level is 27.83% off its SMA20 and 56.89% from its 50-day simple moving average. The RSI (14) is pointing at 81.85 while the volatility over the past week is 0.97% and jumps to 3.31% over the past one month. The beta value is -0.71, while the average true range (ATR) is currently pointing at 0.74.

Coming back to Fusion Pharmaceuticals Inc (NASDAQ:FUSN), we note that the average 3-month trading volume was 2.20 million, while that of the preceding 10-day period stands at 2.03 million. Current shares outstanding are 79.70 million.

The insiders hold 38.59% of the company’s shares while institutions hold 49.96%. The data shows that short shares as of Mar 15, 2024, stood at 7.92 million at a short ratio of 6.98. This represents a 9.35% short interest in shares outstanding on Mar 15, 2024. Shares short rose in March from the previous month at 6.8 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 121.85% up in year-to-date price movement.

Most Popular